Daclizumab (Zenapax®) inhibits early interleukin-2 receptor signal transduction events
Autor: | Goebel, Jens *, Stevens, Erica, Forrest, Kathy, Roszman, Thomas L |
---|---|
Zdroj: | In Transplant Immunology 2000 8(3):153-159 |
Databáze: | ScienceDirect |
Externí odkaz: |